Cancer risk after exposure to treatments for ovulation induction (Q37288901)

19 August 2017

Cancer risk after exposure to treatments for ovulation induction (English)

1 reference

19 August 2017

R Calderon-Margalit

1

1 reference

19 August 2017

Y Friedlander

2

1 reference

19 August 2017

R Yanetz

3

1 reference

19 August 2017

K Kleinhaus

4

1 reference

19 August 2017

M C Perrin

5

1 reference

19 August 2017

O Manor

6

1 reference

19 August 2017

S Harlap

7

1 reference

19 August 2017

O Paltiel

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

26 November 2008

1 reference

American Journal of Epidemiology

19 August 2017

1 reference

19 August 2017

169

1 reference

19 August 2017

3

1 reference

19 August 2017

365-375

1 reference

The Jerusalem Perinatal Study cohort, 1964-2005: methods and a review of the main results

19 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Use of postmenopausal hormone replacement therapy and risk of non-Hodgkin's lymphoma: a Danish population-based cohort study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Comparison of uterine malignancies that develop during and following tamoxifen therapy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Comparison of tamoxifen and clomiphene citrate for ovulation induction: a meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Ovulation induction and cancer risk

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Historical perspectives in gonadotrophin therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Cancer incidence following treatment for infertility at a clinic in the UK.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Risk of cancer after use of fertility drugs with in-vitro fertilisation

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Cutaneous malignant melanoma in women. Phenotypic characteristics, sun exposure, and hormonal factors: a case-control study from Italy.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Combined oral contraceptive use and epithelial ovarian cancer risk: time-related effects.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Risk of breast cancer after exposure to fertility drugs: results from a large Danish cohort study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Uterine cancer after use of clomiphene citrate to induce ovulation

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Hormone replacement therapy and risk of lymphomas and myelomas

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Breast cancer risk associated with ovulation-stimulating drugs

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Reproductive and dietary risk factors for epithelial ovarian cancer in China

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Ovulation induction and risk of endometrial cancer: a pilot study

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Reproductive factors and risk of intermediate- or high-grade B-Cell non-Hodgkin's lymphoma in women

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Regional differences in waiting time to pregnancy: pregnancy-based surveys from Denmark, France, Germany, Italy and Sweden. The European Infertility and Subfecundity Study Group.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Cumulative conception and live birth rates after the treatment of anovulatory infertility: safety and efficacy of ovulation induction in 200 patients.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Cutaneous melanoma in women: ovulatory life, menopause, and use of exogenous estrogens.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Oral contraceptives and breast cancer: a cooperative Italian study.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Risk of ovarian cancer after treatment for infertility.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2720715

Menstrual and Reproductive Factors and Risk of Non-Hodgkin's Lymphoma among Connecticut Women

3 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FAJE%2FKWN318

Risk of endometrial cancer after use of fertility drugs

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FAJE%2FKWN318

Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan

21 January 2018

1 reference

12 December 2020

Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia

1 reference

12 December 2020

Ovarian cancer risk after the use of ovulation-stimulating drugs

1 reference

12 December 2020

Use of clomiphene citrate in women

1 reference

12 December 2020

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

1 reference

12 December 2020

Ovarian tumors in a cohort of infertile women

1 reference

12 December 2020

Risk of breast cancer in a cohort of infertile women

1 reference

12 December 2020

Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors

1 reference

12 December 2020

Cancer incidence in a cohort of infertile women

1 reference

12 December 2020

TREATMENT OF AMENORRHEA AND OF ANOVULATION WITH HUMAN MENOPAUSAL AND CHORIONIC GONADOTROPINS

1 reference

12 December 2020

A case-control study of ovarian cancer in relation to infertility and the use of ovulation-inducing drugs

1 reference

12 December 2020

Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs

1 reference

12 December 2020

Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women

1 reference

12 December 2020

Long-term follow-up of the randomized Stockholm trial on adjuvant tamoxifen among postmenopausal patients with early stage breast cancer

1 reference

12 December 2020

Insurance mandates and trends in infertility treatments

1 reference

12 December 2020

Identifiers

DOI

10.1093/AJE/KWN318

1 reference

19 August 2017

1 reference

19 August 2017

1 reference